Physician profile
Eric Kosofsky
NPI 1295712891
$5,499.59
in general payments reported to CMS, 2019-2025
34 companies · $820 in 2025
The $820 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $921 · 2020: $570 · 2021: $273 · 2022: $406 · 2023: $1,261 · 2024: $1,248 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,173 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,172.95 |
| Education | $156.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,914.47 | 2019-2025 | Augment Injectable, Prostep Mica, Citrefix |
| Kerecis Limited | $536.61 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $451.79 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $264.11 | 2022-2025 | |
| Next Science LLC | $249.36 | 2021-2024 | Surgx, Blastx, Xperience |
| Smith+Nephew, INC. | $242.42 | 2019-2024 | Evos, Grafix Pl, Stravix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $194.37 | 2019-2025 | Jublia |
| Davol INC. | $191.04 | 2020 | |
| Solventum Corporation | $149.99 | 2024 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice |
| Axogen | $136.30 | 2019-2023 | Avance Nerve Graft |
| Zimvie INC. | $136.12 | 2023 | |
| Paragon 28, INC. | $119.99 | 2025 | Ankle Fracture |
| Osiris Therapeutics INC. | $115.72 | 2019 | |
| Averitas Pharma INC. | $108.06 | 2023-2024 | Qutenza |
| Abbvie INC. | $99.55 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $94.41 | 2024-2025 | |
| Dynasplint Systems INC. | $67.98 | 2024 | Dynasplint |
| Sebela Pharmaceuticals INC. | $48.57 | 2020-2023 | Naftin |
| Organogenesis INC. | $45.54 | 2019-2022 | |
| Sandoz INC. | $30.43 | 2019 | |
| Reprise Biomedical, INC. | $30.07 | 2024 | Miro3d |
| Hydrofera LLC | $25.64 | 2025 | Hydrofera Blue |
| Osteomed LLC | $24.13 | 2019 | |
| Djo, LLC | $23.49 | 2019 | |
| Aroa Biosurgery Incorporated | $22.18 | 2019 | |
| Convatec INC. | $21.38 | 2023 | |
| Janssen Pharmaceuticals, INC | $20.91 | 2021 | |
| Paratek Pharmaceuticals, INC. | $20.86 | 2024 | Nuzyra |
| In2bones USA, LLC | $20.64 | 2019 | |
| Baxter Healthcare | $20.56 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $20.45 | 2019 | |
| Nabriva Therapeutics, Plc | $19.84 | 2022 | |
| Melinta Therapeutics, LLC | $17.75 | 2019 | |
| Depuy Synthes Sales INC. | $14.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kosofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.